Company
United StatesPublic company, NASDAQ: NVAXNovavax, Inc. (NASDAQ: NVAX), Gaithersburg, MD – FDA Inspections
Inspection records and compliance data for Novavax, Inc. in Gaithersburg, Maryland. 1 FDA inspection on record, last inspected July 08, 2022. Publicly traded as NASDAQ: NVAX.
Company Profile
This profile covers Novavax, Inc. based in Gaithersburg, Maryland, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected July 8, 2022.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 8, 2022 | NAI | Biologics · Bioresearch Monitoring | 1177464 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Novavax, Inc.
Stock ticker
NVAX
Exchange
NASDAQ
Share price
$9.76
Market cap
$1.6B
Price as of
November 6, 2026
FEI Number
3011712917
Address
22 Firstfield Rd, Gaithersburg, Maryland 20878, United States
Country
United States
ID: 76987521-6636-4ecf-9e79-d3bf7e15c1ae